Articles

Browse our regulatory articles below or search through our archive.

 


 

  • 5 QUESTIONS & ANSWERS: STRATEGIC REGULATORY PLANNING FOR YOUNG MEDTEC COMPANIES

    Posted on Nov 06, 2012
    An Interview with Arazy Group President & CEO Benjamin Arazy. 2013 will not be an easy year for MedTech. Last year, MedTec investments in the United States declined by 27% compared to 2011 and this trend is expected to continue. Funding from venture capital funds for this industry have been declining due to a back log of medical device companies seeking an "exit" in the next ten years. The main difficulty will be for startups in the early stages of... Continue reading
latest news
  • Jun 12 2018
    REGULATORY UPDATE - SYNTHETIC MR

    USA: Synthetic MR's SyMRI for Phillips was approved for sale with LICENSALE.COM®. ...

    Read More
  • Jun 12 2018
    REGULATORY UPDATE - TECHNOPATH CLINICAL DIAGNOSTICS

    Italy: Technopath Clinical Diagnostics' Multichem QC was approved for sale with LICENSALE.COM®. ...

    Read More
  • Jun 7 2018
    REGULATORY UPDATE - SPD

    Philippines: SPD's IVD Products for CB11 were approved for sale with LICENSALE.COM®....

    Read More
  • May 29 2018
    REGULATORY UPDATE - ORASURE TECHNOLOGIES

    Burundi: OraSure Technologies' HIVST test kit was approved for sale with LICENSALE.COM®....

    Read More
  • May 25 2018
    JOB POSTING: SOFTWARE ENGINEER/DEVELOPER (STUDENT)

    Arazy Group Consultants Inc. is currently seeking qualified applicants for the position of Software Engineer/Developer. The incumbent will participate in the development and integration of machine learning and gamification within a SaaS application....

    Read More

VANCOUVER OFFICE

  • Phone +1 604.681.6888
  • Fax +1 604.681.6822
  • info@arazygroup.com
  •  
  • #350-1333 Johnston Street
  • Pier 32, Granville Island
  • Vancouver, British Columbia
  • Canada V6H 3R9

BACK TO TOP